Skip to main content

Media Relations

Our Press and Media Relations team offers the latest press releases and background information on a variety of topics as well as image material for download.

Integrated diagnostic solutions for critical care settings

We are committed to improving patient outcomes with innovative diagnostic solutions for acute care that allow the diagnosis, outcome prediction, and monitoring of patients with acute medical conditions.

SphingoTec is a privately held company with its headquarters in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. With a long history of biomarker discovery, development, and validation, SphingoTec develops and markets innovative in vitro diagnostics solutions for its respective novel and proprietary blood-based protein biomarkers. 

Our aspiration is to effectively translate scientific advancements into routine clinical practice. We develop biomarkers addressing diagnostically underserved critical care conditions such as sepsis, acute heart failure, acute kidney injury, and cardiogenic shock. On the Nexus IB10 point-of-care analyzer, clinicians can deploy a wide range of commonly used parameters in acute and critical care settings, making the analyzer a useful addition to intensive care units (ICU), and emergency departments (ED), and other near-patient settings.

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Contact our Press & Media Relations Team

Ruxandra Lenz

Head of Marketing & Communications

Contact

Dr. Ulrike Glaubitz

Senior PR Specialist

Contact

Latest News

26. August 2022
Four units at the University Hospital Heidelberg and Heidelberg Kidney Center implement Proenkephalin (penKid) in a pilot biomarker-based treatment approach to diagnose AKI faster and monitor it more accurately across departments.
Read more
08. August 2022
International medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients during the 4th Scientific Symposium.
Read more
01. August 2022
New findings support the clinical value of the biomarker bio-ADM for triaging sepsis patients in ED, exceeding the prognostic performance of routine biomarkers. So far, the predictive potential of the innovative biomarker has been confirmed and used primarily in ICU. A new study, recently published, confirms its applicability in ED.
Read more

Media Coverage

23. September 2022
Acute kidney injury (AKI) is a life-threatening disease that has no obvious symptoms in the early stages. Early identification of patients with AKI is one of the most critical unmet needs of physicians in their daily clinical practice. The focus of this article is on functional kidney biomarkers since it is not possible for damage markers to estimate the glomerular filtration rate (GFR).
Read more
18. August 2022
International medical leaders discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.
Read more
11. August 2022
During the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.
Read more

Watch our upcoming and latest Webinars on demand

Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. To improve patient management in critical care settings, we have created a series of webinars that look at the latest diagnostic innovations and how they influence today's clinical practice. Click here to see all available Webinars.

07.09.2022

Using bio-ADM and penKid for optimization of AHF management in daily clinical practice

Speaker: Prof. John Parissis MD, PhD,  Attikon General Hospital

28.04.2022:

Using Proenkephalin as a Novel Biomarker to Estimate GFR

Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen

31.03.2022

Point-of-care Diagnostics in the Emergency Department: Better Patient Management

Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome

Press photos for download